Novel Alzheimer's drug gets full FDA approval, though efficacy and risk questioned

Leqembi is first medicine convincingly shown to modestly slow cognitive decline, but some experts say effect too subtle, note dangers

Related Keywords

Washington ,United States ,Japan ,Cambridge ,Cambridgeshire ,United Kingdom ,New York ,Massachusetts ,American ,Japanese ,Americans ,David Duprey ,Teresa Buracchio ,Jason Karlawish ,Alexander Scott ,University At Buffalo In ,Drug Administration ,New York Times ,University Of Pennsylvania Penn Memory Center ,Museum Of Neuroanatomy ,Daily Editionby ,Chiquita Brooks Lasure ,Getty Images ,Penn Memory Center ,